Lataa...

Direct Oral Anticoagulants in CKD: An Update

PURPOSE OF REVIEW: Direct oral anticoagulants (DOACs) are variably eliminated by the kidneys rendering their use potentially problematic in patients with chronic kidney disease (CKD) or necessitating appropriate dose adjustment. RECENT FINDINGS: Both observational and limited randomized trial data f...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Curr Opin Nephrol Hypertens
Päätekijät: Mavrakanas, Thomas A., Charytan, David M., Winkelmayer, Wolfgang C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7769201/
https://ncbi.nlm.nih.gov/pubmed/32740218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNH.0000000000000634
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!